THT 2022
  • About
    • About THT
    • Overview
    • FAQ
    • CME
    • Contact Us
    • Presenter Resources
  • Program
  • Attendance
  • Call For Science
  • Industry
  • Press
  • Register

Registration is Open!

THT 2022 is the first-ever Technology and Heart Failure Therapeutics conference, an immersive, two-day experience in the latest innovations that practitioners can put into practice for treating heart failure.

CRF requires all participants to be fully vaccinated against COVID-19 as a condition of attendance.

CRF will ask you on-site to present proof of full vaccination with an FDA- or WHO-authorized COVID-19 vaccine. Your documentation must show that you are fully vaccinated. According to the CDC, you are considered fully vaccinated:

  • Two weeks after receiving your second dose in a two-dose series, such as the Pfizer or Moderna vaccines, or
  • Two weeks after receiving a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine.

After presenting your vaccine documentation, you will be able to proceed to the badge pick-up table on-site.

See the policy in full.

REGISTER NOW

See information about international travel, if relevant.

CAUTION! Watch out for booking scams! Fraudulent websites can pose as official websites of CRF and THT 2022. See Booking Alert!

CRF Logo

Sign Up for Our Newsletter

Get the latest news and information from CRF.

By submitting your email address, you agree to CRF's Privacy Policy & Terms and Conditions.

1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
[email protected]

© 2021, Cardiovascular Research Foundation. All rights reserved.

Privacy Policy
Terms and Conditions of Use
Manage Cookie Settings